This comprehensive guide explores the critical role of regulatory inspections in clinical research, offering a global perspective on the processes and expectations of key regulatory authorities. The book covers the history, mandates, and inspection methodologies of major bodies such as the FDA, EMA, MHRA, PMDA, Health Canada, TGA, SFDA, and DCGI, while highlighting common findings and strategies to address them effectively.
Readers will gain practical insights into preparing for inspections, managing noncompliance, and crafting robust Corrective and Preventive Action (CAPA) plans. Through detailed case studies and lessons learned, the book illustrates real-world scenarios and actionable strategies for sites, sponsors, and CROs to enhance their readiness and practices.
The book also delves into global trends, including the increased focus on electronic data, decentralized trials, and harmonization efforts under ICH-GCP. With a focus on quality systems and leveraging technology, it provides long-term strategies to maintain compliance and improve trial outcomes.
Ideal for clinical research professionals, this guide equips readers with the tools to navigate inspections confidently and uphold the highest standards in clinical research.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Vendeur : GreatBookPrices, Columbia, MD, Etats-Unis
Etat : As New. Unread book in perfect condition. N° de réf. du vendeur 49737890
Quantité disponible : Plus de 20 disponibles
Vendeur : PBShop.store UK, Fairford, GLOS, Royaume-Uni
PAP. Etat : New. New Book. Shipped from UK. Established seller since 2000. N° de réf. du vendeur L2-9798305549508
Quantité disponible : Plus de 20 disponibles
Vendeur : GreatBookPrices, Columbia, MD, Etats-Unis
Etat : New. N° de réf. du vendeur 49737890-n
Quantité disponible : Plus de 20 disponibles
Vendeur : Ria Christie Collections, Uxbridge, Royaume-Uni
Etat : New. In. N° de réf. du vendeur ria9798305549508_new
Quantité disponible : Plus de 20 disponibles
Vendeur : GreatBookPricesUK, Woodford Green, Royaume-Uni
Etat : New. N° de réf. du vendeur 49737890-n
Quantité disponible : Plus de 20 disponibles
Vendeur : GreatBookPricesUK, Woodford Green, Royaume-Uni
Etat : As New. Unread book in perfect condition. N° de réf. du vendeur 49737890
Quantité disponible : Plus de 20 disponibles
Vendeur : CitiRetail, Stevenage, Royaume-Uni
Paperback. Etat : new. Paperback. This comprehensive guide explores the critical role of regulatory inspections in clinical research, offering a global perspective on the processes and expectations of key regulatory authorities. The book covers the history, mandates, and inspection methodologies of major bodies such as the FDA, EMA, MHRA, PMDA, Health Canada, TGA, SFDA, and DCGI, while highlighting common findings and strategies to address them effectively.Readers will gain practical insights into preparing for inspections, managing noncompliance, and crafting robust Corrective and Preventive Action (CAPA) plans. Through detailed case studies and lessons learned, the book illustrates real-world scenarios and actionable strategies for sites, sponsors, and CROs to enhance their readiness and practices.The book also delves into global trends, including the increased focus on electronic data, decentralized trials, and harmonization efforts under ICH-GCP. With a focus on quality systems and leveraging technology, it provides long-term strategies to maintain compliance and improve trial outcomes.Ideal for clinical research professionals, this guide equips readers with the tools to navigate inspections confidently and uphold the highest standards in clinical research. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability. N° de réf. du vendeur 9798305549508
Quantité disponible : 1 disponible(s)
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
Taschenbuch. Etat : Neu. Neuware - This comprehensive guide explores the critical role of regulatory inspections in clinical research, offering a global perspective on the processes and expectations of key regulatory authorities. The book covers the history, mandates, and inspection methodologies of major bodies such as the FDA, EMA, MHRA, PMDA, Health Canada, TGA, SFDA, and DCGI, while highlighting common findings and strategies to address them effectively.Readers will gain practical insights into preparing for inspections, managing noncompliance, and crafting robust Corrective and Preventive Action (CAPA) plans. Through detailed case studies and lessons learned, the book illustrates real-world scenarios and actionable strategies for sites, sponsors, and CROs to enhance their readiness and practices.The book also delves into global trends, including the increased focus on electronic data, decentralized trials, and harmonization efforts under ICH-GCP. With a focus on quality systems and leveraging technology, it provides long-term strategies to maintain compliance and improve trial outcomes.Ideal for clinical research professionals, this guide equips readers with the tools to navigate inspections confidently and uphold the highest standards in clinical research. N° de réf. du vendeur 9798305549508
Quantité disponible : 2 disponible(s)